Lifecore Biomedical (LFCR) Tops Q3 EPS by 3c ; Offers Guidance

Lifecore Biomedical (NASDAQ: LFCR) reported Q3 EPS of ($0.29), $0.03 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $31.11 million versus the consensus estimate of $26.35 million.

GUIDANCE:

Lifecore Biomedical sees FY2025 revenue of $74-76 million, versus the consensus of $131.9 million.

For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.

You May Also Be Interested In

• Regency Centers (REG) Tops Q2 EPS by 2c
• Arbor Realty Trust (ABR) Tops Q2 EPS by 4c
• Pinnacle Bank (PBNK) Tops Q2 EPS by 25c